PRIMARY STUDY
β-Caryophyllene ameliorates the Alzheimer-like phenotype in APP/PS1 Mice through CB2 receptor activation and the PPARγ pathway.
Key Findings: Agonists of both CB2 and PPARγ receptors improve AD.
Type of Study: Animal Study
Study Result: Positive
Study Location(s): China
Year of Pub: 2014
Cannabinoids Studied: AM-x Synthetic Cannabinoids
Phytocannabinoid Source: Not Applicable
Terpenes Studied: ß-Caryophyllene
Receptors Studied: CB2, PPAR - Gamma
